Reported Earnings • Apr 15
Full year 2026 earnings: EPS misses analyst expectations Full year 2026 results: EPS: JP¥171 (up from JP¥157 in FY 2025). Revenue: JP¥159.1b (up 6.9% from FY 2025). Net income: JP¥7.23b (up 5.1% from FY 2025). Profit margin: 4.5% (down from 4.6% in FY 2025). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.0%. Revenue is forecast to grow 4.1% p.a. on average during the next 2 years, compared to a 8.8% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • Apr 14
DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 27, 2026 DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 27, 2026. Buy Or Sell Opportunity • Apr 06
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 16% to JP¥3,030. The fair value is estimated to be JP¥2,519, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.4% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 9.5% in 2 years. Earnings are forecast to grow by 21% in the next 2 years. Announcement • Apr 03
DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2026 Results on Apr 14, 2026 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report fiscal year 2026 results on Apr 14, 2026 Upcoming Dividend • Feb 19
Upcoming dividend of JP¥29.00 per share Eligible shareholders must have bought the stock before 26 February 2026. Payment date: 28 May 2026. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (0.9%). Price Target Changed • Jan 20
Price target increased by 7.4% to JP¥2,900 Up from JP¥2,700, the current price target is provided by 1 analyst. New target price is 5.3% above last closing price of JP¥2,753. Stock is up 20% over the past year. The company is forecast to post earnings per share of JP¥174 for next year compared to JP¥157 last year. Reported Earnings • Jan 15
Third quarter 2026 earnings released: EPS: JP¥43.33 (vs JP¥35.79 in 3Q 2025) Third quarter 2026 results: EPS: JP¥43.33 (up from JP¥35.79 in 3Q 2025). Revenue: JP¥40.0b (up 7.6% from 3Q 2025). Net income: JP¥1.82b (up 16% from 3Q 2025). Profit margin: 4.6% (up from 4.2% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Announcement • Jan 14
DOUTOR NICHIRES Holdings Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending February 2026 DOUTOR NICHIRES Holdings Co., Ltd. announced that it has revised its dividend guidance for the fiscal year ending February 2026. For the year ending February 2026, the company has revised its dividend guidance to JPY 29.00 per share against previous guidance of JPY 27.00 per share. Declared Dividend • Nov 19
First half dividend of JP¥27.00 announced Shareholders will receive a dividend of JP¥27.00. Ex-date: 26th February 2026 Payment date: 28th May 2026 Dividend yield will be 2.2%, which is higher than the industry average of 0.6%. Sustainability & Growth Dividend is covered by both earnings (35% earnings payout ratio) and cash flows (51% cash payout ratio). The dividend has increased by an average of 6.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 29% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • Nov 06
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2026 Results on Jan 14, 2026 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q3, 2026 results on Jan 14, 2026 Reported Earnings • Oct 15
Second quarter 2026 earnings released: EPS: JP¥44.17 (vs JP¥41.93 in 2Q 2025) Second quarter 2026 results: EPS: JP¥44.17 (up from JP¥41.93 in 2Q 2025). Revenue: JP¥40.4b (up 5.4% from 2Q 2025). Net income: JP¥1.86b (up 1.1% from 2Q 2025). Profit margin: 4.6% (down from 4.8% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • Oct 03
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 1.3% to JP¥2,581. The fair value is estimated to be JP¥3,227, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has grown by 46%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 22% in the next 2 years. Upcoming Dividend • Aug 21
Upcoming dividend of JP¥27.00 per share Eligible shareholders must have bought the stock before 28 August 2025. Payment date: 19 November 2025. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (0.7%). Announcement • Aug 02
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2026 Results on Oct 14, 2025 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q2, 2026 results on Oct 14, 2025 Reported Earnings • Jul 14
First quarter 2026 earnings released: EPS: JP¥47.83 (vs JP¥54.29 in 1Q 2025) First quarter 2026 results: EPS: JP¥47.83 (down from JP¥54.29 in 1Q 2025). Revenue: JP¥39.3b (up 6.5% from 1Q 2025). Net income: JP¥2.07b (down 13% from 1Q 2025). Profit margin: 5.3% (down from 6.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • Jul 14
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.6% to JP¥2,480. The fair value is estimated to be JP¥3,115, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has grown by 46%. Revenue is forecast to grow by 9.7% in 2 years. Earnings are forecast to grow by 22% in the next 2 years. Announcement • Jul 13
DOUTOR NICHIRES Holdings Co., Ltd. Provides Consolidated Earnings Forecast for the Six Month Ending August 31, 2025 and Fiscal Year Ending February 28, 2026 DOUTOR NICHIRES Holdings Co., Ltd. provided consolidated earnings forecast for the six month ending August 31, 2025 and fiscal year ending February 28, 2026. For the six months period, the company expects net sales of JPY 78,237 million, operating profit of JPY 5,959 million, Profit attributable to owners of parent of JPY 4,093 million and Basic earnings per share JPY 94.38 per share.
For the year ending February 28, 2026, the company expects net sales of JPY 154,514 million, operating profit of JPY 10,599 million, Profit attributable to owners of parent of JPY 7,156 million and Basic earnings per share JPY 165.02 per share. Declared Dividend • Jun 18
Final dividend increased to JP¥27.00 Dividend of JP¥27.00 is 17% higher than last year. Ex-date: 28th August 2025 Payment date: 19th November 2025 Dividend yield will be 2.0%, which is higher than the industry average of 0.6%. Sustainability & Growth Dividend is well covered by both earnings (32% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has increased by an average of 6.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 32% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Jun 03
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: EPS: JP¥157 (up from JP¥125 in FY 2024). Revenue: JP¥148.8b (up 5.8% from FY 2024). Net income: JP¥6.88b (up 25% from FY 2024). Profit margin: 4.6% (up from 3.9% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.3%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Announcement • Apr 28
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2026 Results on Jul 11, 2025 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q1, 2026 results on Jul 11, 2025 Price Target Changed • Apr 21
Price target increased by 13% to JP¥2,700 Up from JP¥2,400, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of JP¥2,743. Stock is up 31% over the past year. The company is forecast to post earnings per share of JP¥168 for next year compared to JP¥157 last year. Valuation Update With 7 Day Price Move • Apr 21
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to JP¥2,742, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Hospitality industry in Japan. Total returns to shareholders of 99% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥2,730 per share. Reported Earnings • Apr 15
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: EPS: JP¥157 (up from JP¥125 in FY 2024). Revenue: JP¥148.8b (up 5.8% from FY 2024). Net income: JP¥6.88b (up 25% from FY 2024). Profit margin: 4.6% (up from 3.9% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.3%. Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 6.7% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 20
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 27 February 2025. Payment date: 29 May 2025. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (0.8%). Announcement • Feb 04
DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2025 Results on Apr 14, 2025 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report fiscal year 2025 results on Apr 14, 2025 Reported Earnings • Jan 15
Third quarter 2025 earnings released: EPS: JP¥35.79 (vs JP¥30.51 in 3Q 2024) Third quarter 2025 results: EPS: JP¥35.79 (up from JP¥30.51 in 3Q 2024). Revenue: JP¥37.2b (up 5.4% from 3Q 2024). Net income: JP¥1.57b (up 17% from 3Q 2024). Profit margin: 4.2% (up from 3.8% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Announcement • Oct 29
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2025 Results on Jan 14, 2025 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q3, 2025 results on Jan 14, 2025 Reported Earnings • Oct 18
Second quarter 2025 earnings released: EPS: JP¥41.93 (vs JP¥36.82 in 2Q 2024) Second quarter 2025 results: EPS: JP¥41.93 (up from JP¥36.82 in 2Q 2024). Revenue: JP¥38.4b (up 7.2% from 2Q 2024). Net income: JP¥1.84b (up 13% from 2Q 2024). Profit margin: 4.8% (up from 4.5% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Aug 22
Upcoming dividend of JP¥23.00 per share Eligible shareholders must have bought the stock before 29 August 2024. Payment date: 18 November 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (0.8%). Announcement • Aug 02
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2025 Results on Oct 15, 2024 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q2, 2025 results on Oct 15, 2024 Reported Earnings • Jul 16
First quarter 2025 earnings released: EPS: JP¥54.29 (vs JP¥45.55 in 1Q 2024) First quarter 2025 results: EPS: JP¥54.29 (up from JP¥45.55 in 1Q 2024). Revenue: JP¥36.9b (up 4.9% from 1Q 2024). Net income: JP¥2.38b (up 18% from 1Q 2024). Profit margin: 6.4% (up from 5.7% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 01
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: JP¥125 (up from JP¥77.55 in FY 2023). Revenue: JP¥140.6b (up 11% from FY 2023). Net income: JP¥5.49b (up 60% from FY 2023). Profit margin: 3.9% (up from 2.7% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.0%. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Announcement • May 03
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2025 Results on Jul 12, 2024 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q1, 2025 results on Jul 12, 2024 Price Target Changed • Apr 23
Price target increased by 9.1% to JP¥2,400 Up from JP¥2,200, the current price target is provided by 1 analyst. New target price is 13% above last closing price of JP¥2,125. Stock is down 2.0% over the past year. The company is forecast to post earnings per share of JP¥145 for next year compared to JP¥125 last year. Reported Earnings • Apr 14
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: JP¥125 (up from JP¥77.55 in FY 2023). Revenue: JP¥140.6b (up 11% from FY 2023). Net income: JP¥5.49b (up 60% from FY 2023). Profit margin: 3.9% (up from 2.7% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.0%. Revenue is forecast to grow 4.9% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Announcement • Apr 14
DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 28, 2024 DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 28, 2024. Upcoming Dividend • Feb 21
Upcoming dividend of JP¥20.00 per share Eligible shareholders must have bought the stock before 28 February 2024. Payment date: 27 May 2024. Payout ratio is a comfortable 29% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (0.6%). Announcement • Jan 31
DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2024 Results on Apr 12, 2024 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report fiscal year 2024 results on Apr 12, 2024 Reported Earnings • Jan 14
Third quarter 2024 earnings released: EPS: JP¥30.51 (vs JP¥9.66 in 3Q 2023) Third quarter 2024 results: EPS: JP¥30.51 (up from JP¥9.66 in 3Q 2023). Revenue: JP¥35.3b (up 9.1% from 3Q 2023). Net income: JP¥1.34b (up 213% from 3Q 2023). Profit margin: 3.8% (up from 1.3% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Announcement • Nov 03
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2024 Results on Jan 12, 2024 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q3, 2024 results on Jan 12, 2024 Reported Earnings • Oct 15
Second quarter 2024 earnings released: EPS: JP¥36.82 (vs JP¥28.18 in 2Q 2023) Second quarter 2024 results: EPS: JP¥36.82 (up from JP¥28.18 in 2Q 2023). Revenue: JP¥35.8b (up 13% from 2Q 2023). Net income: JP¥1.62b (up 30% from 2Q 2023). Profit margin: 4.5% (up from 3.9% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Aug 23
Upcoming dividend of JP¥20.00 per share at 1.4% yield Eligible shareholders must have bought the stock before 30 August 2023. Payment date: 20 November 2023. Payout ratio is a comfortable 32% but the company is not cash flow positive. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (0.5%). Announcement • Aug 18
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2024 Results on Oct 13, 2023 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q2, 2024 results on Oct 13, 2023 Reported Earnings • Jul 16
First quarter 2024 earnings released: EPS: JP¥45.55 (vs JP¥28.99 in 1Q 2023) First quarter 2024 results: EPS: JP¥45.55 (up from JP¥28.99 in 1Q 2023). Revenue: JP¥35.2b (up 15% from 1Q 2023). Net income: JP¥2.01b (up 57% from 1Q 2023). Profit margin: 5.7% (up from 4.2% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 9.2% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • May 31
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2024 Results on Jul 14, 2023 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q1, 2024 results on Jul 14, 2023 Reported Earnings • May 30
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: JP¥77.55 (up from JP¥27.61 in FY 2022). Revenue: JP¥126.9b (up 16% from FY 2022). Net income: JP¥3.43b (up 181% from FY 2022). Profit margin: 2.7% (up from 1.1% in FY 2022). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 37%. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Price Target Changed • May 08
Price target increased by 15% to JP¥2,300 Up from JP¥2,000, the current price target is provided by 1 analyst. New target price is 9.3% above last closing price of JP¥2,104. Stock is up 41% over the past year. The company is forecast to post earnings per share of JP¥122 for next year compared to JP¥77.55 last year. Price Target Changed • Apr 19
Price target increased by 21% to JP¥2,300 Up from JP¥1,900, the current price target is provided by 1 analyst. New target price is 8.3% above last closing price of JP¥2,124. Stock is up 45% over the past year. The company is forecast to post earnings per share of JP¥122 for next year compared to JP¥77.55 last year. Reported Earnings • Apr 16
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: JP¥77.55 (up from JP¥27.61 in FY 2022). Revenue: JP¥126.9b (up 16% from FY 2022). Net income: JP¥3.43b (up 181% from FY 2022). Profit margin: 2.7% (up from 1.1% in FY 2022). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 37%. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 20
Upcoming dividend of JP¥16.00 per share at 1.7% yield Eligible shareholders must have bought the stock before 27 February 2023. Payment date: 26 May 2023. Payout ratio is a comfortable 5.2% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (0.5%). Announcement • Jan 31
DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2023 Results on Apr 14, 2023 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report fiscal year 2023 results on Apr 14, 2023 Major Estimate Revision • Jan 26
Consensus EPS estimates fall by 14% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from JP¥64.80 to JP¥55.75 per share. Revenue forecast steady at JP¥125.4b. Net income forecast to grow 597% next year vs 5.7% growth forecast for Hospitality industry in Japan. Consensus price target up from JP¥1,900 to JP¥2,000. Share price rose 9.0% to JP¥1,862 over the past week. Reported Earnings • Jan 14
Third quarter 2023 earnings released: EPS: JP¥9.66 (vs JP¥35.83 in 3Q 2022) Third quarter 2023 results: EPS: JP¥9.66 (down from JP¥35.83 in 3Q 2022). Revenue: JP¥32.3b (up 15% from 3Q 2022). Net income: JP¥427.0m (down 73% from 3Q 2022). Profit margin: 1.3% (down from 5.6% in 3Q 2022). Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year. Announcement • Jan 13
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2023 Results on Jan 13, 2023 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q3, 2023 results on Jan 13, 2023 Price Target Changed • Nov 16
Price target increased to JP¥1,900 Up from JP¥1,400, the current price target is provided by 1 analyst. New target price is 16% above last closing price of JP¥1,635. Stock is up 1.4% over the past year. The company is forecast to post earnings per share of JP¥64.80 for next year compared to JP¥27.61 last year. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. 1 independent director (7 non-independent directors). Independent Outside Director Masaharu Kono was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Major Estimate Revision • Oct 21
Consensus forecasts updated The consensus outlook for 2023 has been updated. 2023 EPS estimate increased from JP¥58.05 to JP¥64.80. Revenue forecast steady at JP¥124.7b. Net income forecast to grow 91% next year vs 2.2% decline forecast for Hospitality industry in Japan. Consensus price target up from JP¥1,400 to JP¥1,900. Share price fell 5.7% to JP¥1,703 over the past week. Reported Earnings • Oct 17
Second quarter 2023 earnings released: EPS: JP¥28.18 (vs JP¥16.40 in 2Q 2022) Second quarter 2023 results: EPS: JP¥28.18 (up from JP¥16.40 in 2Q 2022). Revenue: JP¥31.6b (up 16% from 2Q 2022). Net income: JP¥1.25b (up 72% from 2Q 2022). Profit margin: 3.9% (up from 2.7% in 2Q 2022). Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Hospitality industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Aug 23
Upcoming dividend of JP¥14.00 per share Eligible shareholders must have bought the stock before 30 August 2022. Payment date: 18 November 2022. Payout ratio is on the higher end at 90%, however this is supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (0.5%). Announcement • Aug 17
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2023 Results on Oct 14, 2022 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q2, 2023 results on Oct 14, 2022 Major Estimate Revision • Jul 25
Consensus forecasts updated The consensus outlook for 2023 has been updated. 2023 EPS estimate increased from JP¥18.10 to JP¥58.05. Revenue forecast steady at JP¥124.8b. Net income forecast to grow 142% next year vs 0.7% decline forecast for Hospitality industry in Japan. Consensus price target of JP¥1,400 unchanged from last update. Share price rose 4.6% to JP¥1,674 over the past week. Reported Earnings • Jul 18
First quarter 2023 earnings released: EPS: JP¥28.99 (vs JP¥29.95 in 1Q 2022) First quarter 2023 results: EPS: JP¥28.99 (down from JP¥29.95 in 1Q 2022). Revenue: JP¥30.5b (up 15% from 1Q 2022). Net income: JP¥1.28b (down 3.2% from 1Q 2022). Profit margin: 4.2% (down from 5.0% in 1Q 2022). Over the next year, revenue is forecast to grow 12%, compared to a 47% growth forecast for the industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. Reported Earnings • Jun 01
Full year 2022 earnings: Revenues miss analyst expectations Full year 2022 results: Revenue: JP¥109.4b (up 14% from FY 2021). Net income: JP¥1.22b (up JP¥12.2b from FY 2021). Profit margin: 1.1% (up from net loss in FY 2021). Revenue missed analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 14%, compared to a 51% growth forecast for the restaurants industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance. Announcement • May 02
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2023 Results on Jul 15, 2022 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q1, 2023 results on Jul 15, 2022 Major Estimate Revision • Apr 27
Consensus forecasts updated The consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥122.6b to JP¥124.3b. EPS estimate fell from JP¥31.90 to JP¥18.10 per share. Net income forecast to shrink 34% next year vs 3.0% decline forecast for Hospitality industry in Japan. Consensus price target of JP¥1,400 unchanged from last update. Share price was steady at JP¥1,468 over the past week. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. 1 independent director (7 non-independent directors). Independent Outside Director Masaharu Kono was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Apr 16
DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 25, 2022 DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 25, 2022. Reported Earnings • Apr 15
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: JP¥27.61 (up from JP¥248 loss in FY 2021). Revenue: JP¥109.4b (up 14% from FY 2021). Net income: JP¥1.22b (up JP¥12.2b from FY 2021). Profit margin: 1.1% (up from net loss in FY 2021). Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 72%. Over the next year, revenue is forecast to grow 12%, compared to a 68% growth forecast for the restaurants industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Feb 18
Upcoming dividend of JP¥12.00 per share Eligible shareholders must have bought the stock before 25 February 2022. Payment date: 26 May 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.5%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (0.4%). Announcement • Jan 30
DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2022 Results on Apr 14, 2022 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report fiscal year 2022 results on Apr 14, 2022 Reported Earnings • Jan 16
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2022 results: EPS: JP¥35.82 (up from JP¥15.67 in 3Q 2021). Revenue: JP¥28.2b (up 3.6% from 3Q 2021). Net income: JP¥1.58b (up 129% from 3Q 2021). Profit margin: 5.6% (up from 2.5% in 3Q 2021). Revenue missed analyst estimates by 4.1%. Earnings per share (EPS) exceeded analyst estimates. Earnings per share (EPS) surpassed analyst estimates. Over the next year, revenue is forecast to grow 15%, compared to a 56% growth forecast for the industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. Reported Earnings • Oct 16
Second quarter 2022 earnings released: EPS JP¥16.40 (vs JP¥30.18 loss in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥27.2b (up 7.2% from 2Q 2021). Net income: JP¥725.0m (up JP¥2.06b from 2Q 2021). Profit margin: 2.7% (up from net loss in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Aug 23
Upcoming dividend of JP¥12.00 per share Eligible shareholders must have bought the stock before 30 August 2021. Payment date: 18 November 2021. Trailing yield: 1.5%. Lower than top quartile of Japanese dividend payers (3.1%). Higher than average of industry peers (0.5%). Reported Earnings • Jul 18
First quarter 2022 earnings released: EPS JP¥29.95 (vs JP¥102 loss in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥26.5b (up 40% from 1Q 2021). Net income: JP¥1.32b (up JP¥5.83b from 1Q 2021). Profit margin: 5.0% (up from net loss in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Reported Earnings • May 29
Full year 2021 earnings released: JP¥248 loss per share (vs JP¥137 profit in FY 2020) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: JP¥96.1b (down 27% from FY 2020). Net loss: JP¥11.0b (down 281% from profit in FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 17
Full year 2021 earnings released: JP¥248 loss per share (vs JP¥137 profit in FY 2020) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: JP¥96.1b (down 27% from FY 2020). Net loss: JP¥11.0b (down 281% from profit in FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Mar 09
New 90-day high: JP¥1,764 The company is up 16% from its price of JP¥1,520 on 09 December 2020. The Japanese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Hospitality industry, which is up 2.0% over the same period. Is New 90 Day High Low • Feb 05
New 90-day high: JP¥1,650 The company is up 13% from its price of JP¥1,464 on 06 November 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Hospitality industry, which is up 8.0% over the same period. Announcement • Feb 03
DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2021 Results on Apr 14, 2021 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report fiscal year 2021 results on Apr 14, 2021 Analyst Estimate Surprise Post Earnings • Jan 19
Revenue and earnings miss expectations Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 5.4%. Over the next year, revenue is forecast to grow 12%, compared to a 12% growth forecast for the Hospitality industry in Japan. Analyst Estimate Surprise Post Earnings • Jan 16
Revenue and earnings miss expectations Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 5.4%. Over the next year, revenue is forecast to grow 12%, compared to a 12% growth forecast for the Hospitality industry in Japan. Reported Earnings • Jan 15
Third quarter 2021 earnings released: EPS JP¥15.67 The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥27.2b (down 17% from 3Q 2020). Net income: JP¥693.0m (down 52% from 3Q 2020). Profit margin: 2.5% (down from 4.4% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Jan 15
New 90-day high: JP¥1,582 The company is up 5.0% from its price of JP¥1,500 on 16 October 2020. The Japanese market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Hospitality industry, which is up 6.0% over the same period. Price Target Changed • Dec 01
Price target lowered to JP¥1,500 Down from JP¥1,900, the current price target is provided by 1 analyst. The new target price is close to the current share price of JP¥1,439. As of last close, the stock is down 35% over the past year. Is New 90 Day High Low • Dec 01
New 90-day low: JP¥1,439 The company is down 12% from its price of JP¥1,642 on 02 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Hospitality industry, which is up 12% over the same period. Announcement • Nov 29
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2021 Results on Jan 14, 2021 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q3, 2021 results on Jan 14, 2021 Announcement • Aug 23
DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2021 Results on Oct 15, 2020 DOUTOR NICHIRES Holdings Co., Ltd. announced that they will report Q2, 2021 results on Oct 15, 2020 
